Vision

Medallia Named a Leader in Text Mining and Analytics by Independent Research Firm

Retrieved on: 
torsdag, maj 30, 2024

Medallia, Inc., the global leader in customer and employee experience, today announced it has been recognized as a leader in The Forrester Wave™: Text Mining and Analytics Platforms, Q2 2024.

Key Points: 
  • Medallia, Inc., the global leader in customer and employee experience, today announced it has been recognized as a leader in The Forrester Wave™: Text Mining and Analytics Platforms, Q2 2024.
  • Medallia received the top scores possible in the Strategy category for the Vision, Innovation, and Adoption criteria.
  • “Understanding unstructured data is at the core of experience management and we are thrilled to be recognized by Forrester as a leader in this text mining and analytics evaluation,” said Simonetta Turek, Chief Product Officer at Medallia.
  • To download The Forrester Wave™: Text Mining and Analytics Platforms, Q2 2024, click here .

Thermo Fisher Scientific Introduces Array-based Solution for Extended Blood Type Research to Support Future Advancements Toward Safer Transfusions

Retrieved on: 
onsdag, maj 15, 2024

Blood typing is a critical medical service used to match blood and tissue types ahead of transfusions and transplants.

Key Points: 
  • Blood typing is a critical medical service used to match blood and tissue types ahead of transfusions and transplants.
  • Therefore, research is critical to bring extended blood typing into strategies to mitigate potential risks of hemolytic transfusion reactions in the future.
  • “The Axiom BloodGenomiX Array and Software provide a cost-effective, high-throughput solution for extended blood typing research,” said Kevin Lowitz, vice president and general manager, microarray solutions at Thermo Fisher Scientific.
  • “In the future, having access to a scalable, array-based blood typing solution may help blood services effectively screen extended blood types for more precise blood matching.”
    For more information, please visit thermofisher.com/extendedbloodtyping and read the white paper, “ Genotyping for extended and rare blood types .”
    *For research use only.

Mojo Vision Demonstrating Micro-LED Advancements at Display Week

Retrieved on: 
tisdag, maj 14, 2024

Mojo Vision , the high-performance micro-LED company, today announced significant display technology advancements at SID Display Week , in San Jose, CA.

Key Points: 
  • Mojo Vision , the high-performance micro-LED company, today announced significant display technology advancements at SID Display Week , in San Jose, CA.
  • Mojo developed a monolithic RGB panel with 4µm pixels and 1.3µm sub-pixels using its proprietary Quantum Dot (QD) and integration processes.
  • “Mojo is advancing human interaction with technology by creating the world’s smallest and densest micro-LED displays,” said Dr. Achin Bhowmik, president of the Society for Information Display and Mojo Vision Board of Directors member.
  • Mojo’s advancements will provide significant benefits to manufacturers as they incorporate micro-LED into the next generation of product.”
    Both demonstrations will be available at Mojo Vision’s private meeting room at Display Week 2024 from May 14-16, 2024.

Revive Adds First-of-its-Kind Neighborhood Report Feature to Vision AI, Transforming Real Estate Valuations with AI-Driven Condition Analysis

Retrieved on: 
tisdag, maj 14, 2024

This "groundbreaking feature takes CMA data analysis to the next level and is now part of Revive Vision AI ."

Key Points: 
  • This "groundbreaking feature takes CMA data analysis to the next level and is now part of Revive Vision AI ."
  • According to Dalip Jaggi, co-founder of Revive, Neighborhood Report uses advanced AI to provide real estate agents and homeowners with unprecedented condition insights into the homes that recently sold in a neighborhood.
  • "Our release of Vision AI last year was a fresh, groundbreaking use of how computer vision can be used in real estate.
  • The Neighborhood Report feature is now available to all Revive Vision AI users, accessible via both the desktop platform and mobile application.

Vision Films Set Summer Release for Rom-Com 'A Rocky Mountain Affair'

Retrieved on: 
tisdag, maj 14, 2024

LOS ANGELES, May 14, 2024 /PRNewswire/ -- Vision Films Inc. ("Vision") announces the US Transactional VOD release of the feature film A Rocky Mountain Affair on June 6, 2024 in a deal with Scott J. Jones and Artist View Entertainment.

Key Points: 
  • LOS ANGELES, May 14, 2024 /PRNewswire/ -- Vision Films Inc. ("Vision") announces the US Transactional VOD release of the feature film A Rocky Mountain Affair on June 6, 2024 in a deal with Scott J. Jones and Artist View Entertainment.
  • Shot entirely on location in the Canadian Rocky Mountains just outside of Calgary, this fish-out-of-water rom-com embraces the outdoors and rustic environment.
  • Lise Romanoff, CEO and Managing Director of Vision Films says, "A Rocky Mountain Affair is the perfect rom com for the summer!
  • With just the right blend of humor and tenderness all set within the beauty of the majestic Canadian Rockies."

Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold

Retrieved on: 
torsdag, maj 9, 2024

BOCA RATON, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three months ended March 31, 2024.

Key Points: 
  • Revenues for the first quarter of 2024 were $10.7 million, compared with $3.4 million for the first quarter of 2023, an increase of $7.3 million, or 215%.
  • Other income of $0.2 million for the first quarter of 2024 was mostly related to interest income, and was unchanged from the prior-year quarter.
  • Adjusted EBITDA for the first quarter of 2024 was $3.0 million, compared with negative $2.7 million for the first quarter of 2023.
  • Non-GAAP financial measures are not formally defined by GAAP, and other entities may use calculation methods that differ from those used by Sensus Healthcare.

SkinCure Oncology’s GentleCure™ Experience to be Featured in National Public Health PSA Series

Retrieved on: 
onsdag, maj 8, 2024

The PSA is being produced independently by World Impact Productions as part of the acclaimed “Breakthrough” TV PSA series.

Key Points: 
  • The PSA is being produced independently by World Impact Productions as part of the acclaimed “Breakthrough” TV PSA series.
  • The educational public health series has been developed in collaboration with input from the National Center for Health Statistics, the National Institutes of Health and various think tanks and government agencies.
  • The order, placed in fourth quarter 2023, provides for delivery of approximately 75 units from fourth quarter 2023 through third quarter 2024.
  • The Company anticipates this will address its needs through ultimate finalization and clearance of its technology currently under development.

Sensus Healthcare Announces Sale of First SRT-100 Vision™ System to Asia

Retrieved on: 
måndag, maj 6, 2024

BOCA RATON, Fla, May 06, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces the sale of the first SRT-100 Vision™ (IG-SRT) system in Asia, to Far Eastern Memorial Hospital in Taiwan.  The hospital, which has more than 1,000 beds, is one of the largest private hospitals in Taiwan.

Key Points: 
  • “We are delighted to sell the first SRT-100 Vision system in Asia, in particular to such a prominent hospital as Far Eastern Memorial,” said Benson Suen, Sensus Healthcare’s Vice President of Internation Sales.
  • “We are optimistic this sale will open the door to additional sales of our premium-featured Vision system in the region, including across China.
  • Sentinel™ technology, which contains HIPAA-compliant software with clinical, billing and asset-management utility also may be available in this system.
  • In addition, last year Sensus introduced an important new and improved high-resolution ultrasound technology to provide See & Treat capability.

Wildix UK & Ireland Announce Strategic Leadership Transition to Spearhead Market Expansion and Innovation

Retrieved on: 
torsdag, maj 9, 2024

Wildix, a pioneering provider of Unified Communications as a Service (UCaaS) solutions in Europe, today announced a strategic leadership transition designed to propel the company's market growth.

Key Points: 
  • Wildix, a pioneering provider of Unified Communications as a Service (UCaaS) solutions in Europe, today announced a strategic leadership transition designed to propel the company's market growth.
  • Rob Loakes will take over as Wildix UK Country Manager, succeeding Ian Rowan who steps in as the CEO of x-hoppers.
  • "I am thrilled to lead Wildix UK at such a pivotal time,” said Rob Loakes, Country Manager, Wildix.
  • His deep understanding of Wildix’s operations, partner needs and market strategies will be instrumental in driving the company’s expansion and enhancing its position in the UK market.

Former Intern, Jake Lucas, Brings His Talent to the Full Sail Partners' Technology Team Full-Time

Retrieved on: 
onsdag, maj 8, 2024

STEAMBOAT SPRINGS, Colo., May 8, 2024 /PRNewswire-PRWeb/ -- Full Sail Partners, a Deltek Premier Partner, is happy to announce the promotion of another former intern. Jake Lucas has been promoted to a Full-Time AI Developer with our Technology team. In his new role, he will be innovating ways to leverage AI to further enhance our support and services operations.

Key Points: 
  • Jake Lucas has been promoted to a Full-Time AI Developer with our Technology team.
  • In his new role, he will be innovating ways to leverage AI to further enhance our support and services operations.
  • Bringing Jake on board full-time gives our Technology team another boost in problem-solving and time-saving capabilities.
  • For more information, please contact Full Sail Partners' Marketing and Communications Department or visit the Full Sail Partners' website at http://www.fullsailpartners.com.